Genetic Polymorphism of Matrix Metalloproteinase-9 and Susceptibility to Myocardial Infarction: A Meta-Analysis
Related Experiment Video
Updated: Oct 5, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Beili Feng1,2, Hengdong Li1,2
1Department of Cardiology, HwaMei Hospital, University of Chinese Academy of Sciences, Ningbo, Zhejiang, China.
Objective:
Current findings on the association between MMP-9 rs3918242 and susceptibility to myocardial infarction (MI) are inconsistent, and their definite relationship is discussed in this meta-analysis.
Methods:
Eligible literatures reporting MMP-9 rs3918242 and susceptibility to MI were searched in PubMed, Cochrane Library, CNRI, and VIP using keywords such as "MMP-9", "matrix metallopeptidase-9" and "myocardial infarction", "acute myocardial infarction", "AMI", and "polymorphism". Data from eligible literatures were extracted for calculating OR and corresponding 95% CI using RevMan 5.3 and STATA12.0.
Results:
Ten independent literatures reporting MMP-9 rs3918242 and susceptibility to MI were enrolled. Compared with subjects carrying CT&TT genotype of MMP-9 rs3918242, susceptibility to MI was lower in those carrying CC genotype (OR = 1.49, 95%CI = 1.19-1.86, P = 0.0004). Such a significance was observed in the overdominant (OR = 1.27, 95%CI = 1.14-1.41, P < 0.0001) and allele genetic models (OR = 1.43, 95%CI = 1.17-1.74, P = 0.0005) as well. This finding was also valid in the Asian population.
Conclusions:
Mutation on MMP-9 rs3918242 has a potential relevance with susceptibility to MI.
Insights
The MMP-9 rs3918242 CC genotype is associated with a lower risk of myocardial infarction (MI). This genetic variant, matrix metallopeptidase-9 rs3918242, shows potential relevance to MI susceptibility, particularly in Asian populations.
Area of Science:
- Genetics
- Cardiovascular Disease
- Molecular Biology
Background:
- Inconsistent findings exist regarding the association between MMP-9 rs3918242 and myocardial infarction (MI) susceptibility.
- Matrix metallopeptidase-9 (MMP-9) plays a role in cardiovascular health.
- Polymorphisms in MMP-9 may influence MI risk.
Purpose of the Study:
- To conduct a meta-analysis to clarify the relationship between MMP-9 rs3918242 and susceptibility to MI.
- To consolidate existing evidence on the genetic association of MMP-9 rs3918242 with MI.
- To investigate the role of MMP-9 rs3918242 in MI risk.
Main Methods:
- A systematic literature search was performed in PubMed, Cochrane Library, CNRI, and VIP.
- Keywords included "MMP-9", "matrix metallopeptidase-9", "myocardial infarction", "acute myocardial infarction", "AMI", and "polymorphism".
- Data from 10 eligible studies were extracted and analyzed using RevMan 5.3 and STATA12.0 to calculate odds ratios (OR) and 95% confidence intervals (CI).
Main Results:
- The CC genotype of MMP-9 rs3918242 was associated with lower MI susceptibility compared to CT&TT genotypes (OR = 1.49, 95%CI = 1.19-1.86, P = 0.0004).
- Significant associations were found in overdominant (OR = 1.27, 95%CI = 1.14-1.41, P < 0.0001) and allele genetic models (OR = 1.43, 95%CI = 1.17-1.74, P = 0.0005).
- These findings were consistent in the Asian population.
Conclusions:
- The mutation on MMP-9 rs3918242 demonstrates a potential relevance to MI susceptibility.
- The CC genotype may confer a protective effect against myocardial infarction.
- Further research into MMP-9 rs3918242's role in cardiovascular disease is warranted.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Myocarditis I: Introduction
Single Nucleotide Polymorphisms-SNPs

